BRCA2 and sarcoma: Mutations in the HR genes BRCA1 and BRCA2 and mutational signatures of BRCA deficiency were previously identified in soft tissue and bone sarcoma patients, which provided the first indication of HRDness in sarcomas (Kovac et al, 2015; Seligson et al, 2019; Li et al, 2020).